# Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging

> **NCT05043519** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Cranial Nerve Injuries

## Interventions

- **DRUG:** FAM-NP41

## Key facts

- **NCT ID:** NCT05043519
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043519, "Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05043519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*